Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Number To Know…3

Executive Summary

Only three leadless pacemakers have been CE marked to date, as revealed following the publication of recent UK guidelines on how to evaluate such products.

There are only three leadless cardiac pacemakers that have received a CE-mark to date, according to a recent guideline issued by the UK Medicines and Healthcare products Regulatory Agency on the clinical evaluation of such products. At the time of writing the March 2017 guideline, the MHRA said CE-marks had been awarded to St. Jude Medical Inc. ’s Nanostim and Medtronic PLC ’s Micra – both of which are intracardiac, entirely self-contained rate-responsive ventricular demand (VVIR) pacemakers. Also, CE-mark had been granted to EBR Systems Inc.WICS, which effectively adds CRT (cardiac resynchronization therapy) capability to an existing transvenous Implanted pacemaker/implantable cardioverter defibrillator. Other leadless pacing systems are in development and it is thought that this modality may one day provide a wider range of therapies, including multisite endo- or epicardial pacing for CRT plus antitachycardia pacing in combination with non-transvenous ICDs.

To gain more insight on MHRA’s guideline on this topic, read Medtech Insight’s article here.


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts